{"id":"NCT02914275","sponsor":"Seqirus","briefTitle":"A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age.","officialTitle":"A Phase 3, Randomized, Multicenter, Observer-blinded, Noninferiority Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Inactivated Influenza Virus Vaccine (Seqirus QIV) With a US-licensed Quadrivalent Inactivated Comparator Influenza Virus Vaccine (Comparator QIV) in a Pediatric Population 6 Months Through 59 Months of Age","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-09-27","primaryCompletion":"2017-03-09","completion":"2017-08-11","firstPosted":"2016-09-26","resultsPosted":"2019-01-23","lastUpdate":"2019-01-23"},"enrollment":2250,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Influenza, Human"],"interventions":[{"type":"BIOLOGICAL","name":"Seqirus Quadrivalent Inactivated Influenza Vaccine","otherNames":["Seqirus QIV"]},{"type":"BIOLOGICAL","name":"Comparator Quadrivalent Inactivated Influenza Vaccine","otherNames":["Comparator QIV"]}],"arms":[{"label":"Seqirus QIV Cohort A","type":"EXPERIMENTAL"},{"label":"Seqirus QIV Cohort B","type":"EXPERIMENTAL"},{"label":"Comparator QIV Cohort A","type":"ACTIVE_COMPARATOR"},{"label":"Comparator QIV Cohort B","type":"ACTIVE_COMPARATOR"}],"summary":"This is a study to assess the immune (antibody) response and safety of a Seqirus split virion, inactivated Quadrivalent Influenza Vaccine (Seqirus QIV), in comparison with a US licensed 2016/2017 Quadrivalent Influenza Vaccine (comparator QIV) in a healthy pediatric population 6 months through 59 months of age.","primaryOutcome":{"measure":"The Geometric Mean Titer (GMT) Ratio of Each Virus Strain.","timeFrame":"Postvaccination (28 days after last vaccination)","effectByArm":[{"arm":"Seqirus QIV","deltaMin":370,"sd":null},{"arm":"Comparator QIV","deltaMin":311.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"6 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":16},"locations":{"siteCount":39,"countries":["United States"]},"refs":{"pmids":["30057283"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":1673},"commonTop":["Cough","Rhinorrhoea","Pyrexia","Upper respiratory tract infection"]}}